US Patent 10159751 ExPEC glycoconjugate vaccine formulations
Patent 10159751 was granted and assigned to Janssen Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 24, 2017
Date of Patent
December 25, 2018
Patent Applicant
Patent Application Number
15792242
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10159751 ExPEC glycoconjugate vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
